Tuberculosis incidence in prisons: a systematic review

Iacopo Baussano, Brian G Williams, Paul Nunn, Marta Beggiato, Ugo Fedeli, Fabio Scano, Iacopo Baussano, Brian G Williams, Paul Nunn, Marta Beggiato, Ugo Fedeli, Fabio Scano

Abstract

Background: Transmission of tuberculosis (TB) in prisons has been reported worldwide to be much higher than that reported for the corresponding general population.

Methods and findings: A systematic review has been performed to assess the risk of incident latent tuberculosis infection (LTBI) and TB disease in prisons, as compared to the incidence in the corresponding local general population, and to estimate the fraction of TB in the general population attributable (PAF%) to transmission within prisons. Primary peer-reviewed studies have been searched to assess the incidence of LTBI and/or TB within prisons published until June 2010; both inmates and prison staff were considered. Studies, which were independently screened by two reviewers, were eligible for inclusion if they reported the incidence of LTBI and TB disease in prisons. Available data were collected from 23 studies out of 582 potentially relevant unique citations. Five studies from the US and one from Brazil were available to assess the incidence of LTBI in prisons, while 19 studies were available to assess the incidence of TB. The median estimated annual incidence rate ratio (IRR) for LTBI and TB were 26.4 (interquartile range [IQR]: 13.0-61.8) and 23.0 (IQR: 11.7-36.1), respectively. The median estimated fraction (PAF%) of tuberculosis in the general population attributable to the exposure in prisons for TB was 8.5% (IQR: 1.9%-17.9%) and 6.3% (IQR: 2.7%-17.2%) in high- and middle/low-income countries, respectively.

Conclusions: The very high IRR and the substantial population attributable fraction show that much better TB control in prisons could potentially protect prisoners and staff from within-prison spread of TB and would significantly reduce the national burden of TB. Future studies should measure the impact of the conditions in prisons on TB transmission and assess the population attributable risk of prison-to-community spread. Please see later in the article for the Editors' Summary.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Flow diagram for study selection.
Figure 1. Flow diagram for study selection.
Figure 2. Forest plot showing the study-specific…
Figure 2. Forest plot showing the study-specific estimates of the IRRs for LTBI in prisons as compared to corresponding general populations, by income area according to the World Bank classification.
Source: .
Figure 3. Forest plot showing the study-specific…
Figure 3. Forest plot showing the study-specific estimates of the IRR for tuberculosis in prisons as compared to the corresponding general populations, by income area according to the World Bank classification.
Source: . NA, not applicable.
Figure 4. Contour plot showing the relationship…
Figure 4. Contour plot showing the relationship between the proportion of exposed population, IRR, and PAF%.
X-axis reports the proportion of the population in prison, Y-axis reports the PAF on a log scale calculated using the Levin's formula . The isoclines represent different levels of IRR. Klopf et al. reported TB incidence *before and **after implementation of a TB control program in New York State Department of Correctional Services and prisons personnel separately. Russkikh et al. reported TB incidence among prison personnel †during and ‡following the socioeconomic crisis occurred in Russia in the late 1990s .

References

    1. Angie B, Ann A, Malgosia G, Michael K, Hans K, et al. Geneva: World Health Organization; 2000. Tuberculosis control in prisons: A Manual for Programme Managers.
    1. Dara M, Grzemska M, Kimerling ME, Reyes H, Zagorskiy A. The Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), US Agency for International Development; 2009. Guidelines for control of tuberculosis in prisons.
    1. Reyes H, Coninx R. Pitfalls of tuberculosis programmes in prisons. BMJ. 1997;315:1447–1450.
    1. Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A. 2008;105:13280–13285.
    1. Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health. 2006;120:33–41.
    1. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1–141.
    1. World Health Organization Global Health Atlas. Available: . Accessed 19 November 2010.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
    1. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9:531–541.
    1. United Nations Development Programme. New York, USA: Human Development Report; 2008.
    1. Walmsley R. London: International Centre for Prison Studies, King's College; 2009. World Prison Population List (8th edition).
    1. World Bank. 2008. World Bank Country Classification. Available: . Accessed 19 November 2010.
    1. Wells G, Shea B, O'Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: . Accessed 16 November 2010.
    1. Chaves F, Dronda F, Cave MD, Alonso-Sanz M, Gonzalez-Lopez A, et al. A longitudinal study of transmission of tuberculosis in a large prison population. Am J Respir Crit Care Med. 1997;155:719–725.
    1. Fernandez de la Hoz K, Inigo J, Fernandez-Martin JI, Arce A, Alonso-Sanz M, et al. The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis. 2001;5:696–702.
    1. Ferreira MM, Ferrazoli L, Palaci M, Salles PS, Medeiros LA, et al. Tuberculosis and HIV infection among female inmates in Sao Paulo, Brazil: a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:177–183.
    1. Hanau-Bercot B, Gremy I, Raskine L, Bizet J, Gutierrez MC, et al. A one-year prospective study (1994–1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis. 2000;4:853–859.
    1. Hung R, Shelton S, Rischitelli G. Risk factors for tuberculosis conversion in a state prison. McGill J Med. 2002;7:26–31.
    1. Ijaz K, Yang Z, Templeton G, Stead WW, Bates JH, et al. Persistence of a strain of Mycobacterium tuberculosis in a prison system. Int J Tuberc Lung Dis. 2004;8:994–1000.
    1. Jones TF, Craig AS, Valway SE, Woodley CL, Schaffner W. Transmission of tuberculosis in a jail. Ann Intern Med. 1999;131:557–563.
    1. Klopf LC. Tuberculosis control in the New York State Department of Correctional Services: a case management approach. Am J Infect Control. 1998;26:534–537.
    1. Koffi N, Ngom AK, Aka-Danguy E, Seka A, Akoto A, et al. Smear positive pulmonary tuberculosis in a prison setting: experience in the penal camp of Bouake, Ivory Coast. Int J Tuberc Lung Dis. 1997;1:250–253.
    1. Koo DT, Baron RC, Rutherford GW. Transmission of Mycobacterium tuberculosis in a California State Prison, 1991. Am J Public Health. 1997;87:279–282.
    1. MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NM. Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis. 1997;24:1060–1067.
    1. March F, Coll P, Guerrero RA, Busquets E, Cayla JA, et al. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS. 2000;14:525–535.
    1. Martin V, Guerra JM, Cayla JA, Rodriguez JC, Blanco MD, et al. Incidence of tuberculosis and the importance of treatment of latent tuberculosis infection in a Spanish prison population. Int J Tuberc Lung Dis. 2001;5:926–932.
    1. Mitchell CS, Gershon RR, Lears MK, Vlahov D, Felknor S, et al. Risk of tuberculosis in correctional healthcare workers. J Occup Environ Med. 2005;47:580–586.
    1. Mor Z, Adler A, Leventhal A, Volovic I, Rosenfeld E, et al. Tuberculosis behind bars in Israel: policy making within a dynamic situation. Isr Med Assoc J. 2008;10:202–206.
    1. Slavuckij A, Sizaire V, Lobera L, Matthys F, Kimerling ME. Decentralization of the DOTS programme within a Russian penitentiary system. How to ensure the continuity of tuberculosis treatment in pre-trial detention centres. Eur J Public Health. 2002;12:94–98.
    1. Steenland K, Levine AJ, Sieber K, Schulte P, Aziz D. Incidence of tuberculosis infection among New York State prison employees. Am J Public Health. 1997;87:2012–2014.
    1. Valway SE, Richards SB, Kovacovich J, Greifinger RB, Crawford JT, et al. Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol. 1994;140:113–122.
    1. Wong MY, Leung CC, Tam CM, Kam KM, Ma CH, et al. TB surveillance in correctional institutions in Hong Kong, 1999–2005. Int J Tuberc Lung Dis. 2008;12:93–98.
    1. Braun MM, Truman BI, Maguire B, DiFerdinando GT, Jr, Wormser G, et al. Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA. 1989;261:393–397.
    1. de Oliveira HB, Cardoso JC. [Tuberculosis among city jail inmates in Campinas, Sao Paulo, Brazil]. Rev Panam Salud Publica. 2004;15:194–199.
    1. Russkikh OE. Probl Tuberk Bolezn Legk; 2007. [Comparative analysis of tuberculosis morbidity trends in the penitentiary and civil health care systems of the Udmurt Republic over 10 years]. pp. 38–39.
    1. Pavlov Iu A, Punga VV. Probl Tuberk Bolezn Legk; 2003. [Organization of tuberculosis-controlling work and its efficiency in the penitentiaries of the Ivanovo Region]. pp. 3–5.
    1. Aerts A, Hauer B, Wanlin M, Veen J. Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis. 2006;10:1215–1223.
    1. Zarate E, Lobón I, Saavedra C, Castañeda M. [Tuberculosis new scenery: prison establishments]. An Fac Med Lima. 2005;66:148–158.
    1. Kimerling M. Tuberculosis in Prisons. In: Raviglione M, editor. Reichman and Hershfield's Tuberculosis: A Comprehensive International Approach. 3rd ed. New York: Informa Healthcare; 2006. pp. 921–948.
    1. Matthys F, Rigouts L, Sizaire V, Vezhnina N, Lecoq M, et al. Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLoS One. 2009;4:e7954. doi: .
    1. Coninx R, Maher D, Reyes H, Grzemska M. Tuberculosis in prisons in countries with high prevalence. BMJ. 2000;320:440–442.
    1. Scano F. Geneva, Switzerland: World Health Organization; 2009. WHO policy on TB infection control in health-care facilities, congregate settings and households.
    1. Larouze B, Sanchez A, Diuana V. Tuberculosis behind bars in developing countries: a hidden shame to public health. Trans R Soc Trop Med Hyg. 2008;102:841–842.
    1. Arshad S, Bavan L, Gajari K, Paget SN, Baussano I. Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J. 2009;35:1336–1345.
    1. Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006;3:e494. doi: .
    1. Lobacheva T, Sazhin V, Vdovichenko E, Giesecke J. Pulmonary tuberculosis in two remand prisons (SIZOs) in St Petersburg, Russia. Euro Surveill. 2005;10:93–96.
    1. United Nations DevelopmentProgramme. New York, USA: Human Development Report 2009; 2009.
    1. Rodrigo T, Cayla JA, Garcia de Olalla P, Brugal MT, Jansa JM, et al. Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987–2000. Int J Tuberc Lung Dis. 2002;6:1091–1097.
    1. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007;11:593–605.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren